ProMIS Neurosciences, Inc.
+4.1% · 90d
$11.10
-0.14 (-1.24%)
News
(1)April 2026
ProMIS Neurosciences Inc. — DEF 14A Filing
PMNProMIS Neurosciences Inc.
# 📜 What This Document Is This is a **DEF 14A** (Definitive Proxy Statement) for ProMIS Neurosciences. Think of it as a detailed invitation and instruction manual for the company's **2026 Annual Shareholder Meeting**. It tells shareholders what's being voted on, who the candidates are, and how the
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%